SCHEMBL5683284

SCHEMBL5683284

Cc1cccc(S(=O)(=O)Cl)c1-c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.47
FABP4 P15090 2/20 0.41
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP3A4 P08684 2/20 0.38
KDM4E B2RXH2 2/20 0.38
POLB P06746 1/20 0.38
CYP2C9 P11712 1/20 0.38
RPA1 P27694 1/20 0.37
MCL1 Q07820 1/20 0.37
FGFR1 P11362 1/20 0.37
FGFR2 P21802 1/20 0.37
FGFR4 P22455 1/20 0.37
FGFR3 P22607 1/20 0.37
FABP3 P05413 1/20 0.37
MYC P01106 1/20 0.37
CA12 O43570 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4142033 0.85 CASP1 (0.49) CASP1FABP4ALDH1A1CYP3A4KDM4E
SCHEMBL7366744 0.84 L3MBTL1 (0.41) CASP1ALDH1A1CA1CA2CA5A
SCHEMBL4759798 0.83 CASP1 (0.48) CASP1FABP4CYP3A4CYP2C9CA12
SCHEMBL30950298 0.78 ALDH1A1 (0.44) ALDH1A1HSD17B10TDP1KDM4EPOLB
SCHEMBL4439 0.78 ALDH1A1 (0.44) ALDH1A1HSD17B10TDP1KDM4EPOLB
SCHEMBL12097036 0.77 CASP1 (0.44) CASP1FABP4TDP1CYP3A4KDM4E
Water SCHEMBL9476427 0.76 ALDH1A1 (0.42) ALDH1A1HSD17B10TDP1KDM4EPOLB
SCHEMBL1584604 0.76 ALDH1A1 (0.48) ALDH1A1HSD17B10TDP1KDM4EPOLB
SCHEMBL1109716 0.76 ALDH1A1 (0.42) ALDH1A1HSD17B10TDP1KDM4EPOLB
SCHEMBL1584603 0.76 ALDH1A1 (0.42) ALDH1A1HSD17B10TDP1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0932600-B1 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1BETA CONVERTING ENZYME INHIBITORS WARNER LAMBERT CO (US) 2006-02-08 EP disclosed
US-6083981-A USEFUL FOR TREATMENT OF STROKE, INFLAMMATORY DISEASES, SEPTIC SHOCK, REPERFUSION INJURY, ALZHEIMER'S DISEASE, SHIGELLOSIS WARNER-LAMBERT COMPANY (US) 2000-07-04 US disclosed
US-6054487-A ADMINISTERING AN INTERLEUKIN-ONE BETA CONVERTING ENZYME SUFFICIENT TO INHIBIT PRODUCTION OF GAMMA-INTERFERON BASF AKTIENGESELLSCHAFT (DE) 2000-04-25 US disclosed